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Abstract The most prominent capabilities of mesenchymal
stem cells (MCSs) which make them promising for thera-
peutic applications are their capacity to endure and implant
in the target tissue. However, the therapeutic applications of
these cells are limited due to their early death within the first
few days following transplantation. Therefore, to improve
cell therapy efficacy, it is necessary to manipulate MSCs to
resist severe stresses imposed by microenvironment. In this
study, we manipulated MSCs to express a cytoprotective
factor, nuclear factor erythroid-2 related factor 2 (Nrf2) to
address this issue. Full-length human Nrf2 cDNA was iso-
lated and TOPO cloned into TOPO cloning vector and then
transferred to gateway adapted adenovirus expression vector
by LR recombination reaction. Afterwards, the Nrf2 bearing
recombinant virus was prepared in appropriate mammalian
cell line and used to infect MSCs. The viability and apopto-
sis of the Nrf2 expressing MSCs were evaluated following
hypoxic and oxidative stress conditions. Transient expres-
sion of Nrf2 by MSCs protected them against cell death and
the apoptosis triggered by hypoxic and oxidative stress
conditions. Nrf2 also enhanced the activity of SOD and
HO-1. These findings could be used as a strategy for pre-
vention of graft cell death in MSC-based cell therapy. It also
indicates that management of cellular stress responses can
be used for practical applications.
Keywords Mesenchymal stem cells . Nrf2 . Adenoviral
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Introduction
Mesenchymal stem cells (MSCs) maintain self renewality
and are capable to differentiate into osteoblasts, chondro-
cytes, astrocytes, neurons, skeletal muscle cells, and cardi-
omyocytes (Liu et al. 2009; Makino et al. 1999; Pereira et al.
1995; Toma et al. 2002). Multilineage potential, ability to
evade from host immune system, immunomodulatory ca-
pacities, and being easy to expand in vitro, make MSCs
promising for cell therapy applications. Transplantation of
MSCs is an effective treatment in tissue injuries including
myocardial infarction, hind limb ischemia, acute renal fail-
ure, and liver transplantation (Zhang et al. 2009; Kinnaird et
al. 2004; Iwase et al. 2005). In spite of several advantages of
MSCs, they did not achieve satisfactory effects in some
investigations, mostly due to poor survival after transplan-
tation (Toma et al. 2002; Kolossov et al. 2006; LIU et al.
2008; Lunde et al. 2006; Zhang et al. 2001). For example,
more than 99% of transplanted MSCs have died 1 day after
transplantation. The reasons of low survival rate of MSCs
are not fully understood. However, it is noteworthy that
M. Mohammadzadeh : R. Halabian :N. Amirizadeh :
M. H. Roudkenar (*)
Blood Transfusion Research Center, High Institute for Research
and Education in Transfusion Medicine,
P.O. Box 14665-1157 Tehran, Iran
e-mail: roudkenar@ibto.ir
A. Gharehbaghian
Medical Laboratory Sciences Department, School of Allied Medical
Sciences, Shahid Beheshti University of Medical Sciences,
Tehran, Iran
A. Jahanian-Najafabadi
Department of Molecular Biology, Pasteur Institute of Iran,
Tehran, Iran
A. M. Roushandeh
Department of Anatomy, Faculty of Medicine,
Hamadan University of Medical Sciences,
Hamadan, Iran
Cell Stress and Chaperones (2012) 17:553–565
DOI 10.1007/s12192-012-0331-9
during isolation and processing of the MSCs from their
natural niche, they are inevitably exposed to stress condi-
tions such as, serum deprivation, hypoxia, and oxidative
stresses (Zhu et al. 2006b). On the other hand, due to
inflammation, chemotherapy, radiotherapy, and expression
of pro-apoptotic factors, the microenvironment of damaged
tissue in patients who receive MSCs as treatment does not
favor the survival of MSCs. Hence, it is necessary to rein-
force the MSCs to withstand the rigors of the stresses to
develop an effective therapeutic modality.
Novel strategies are being developed to modify biologi-
cal and functional properties of MSCs, such as preparation
of the cells in special bioscaffolds, preconditioning of the
cells in culture, and genetic alterations (Zhang et al. 2011).
The latter strategy usually implies introduction of a cyto-
protective factor into MSCs before transplantation which
could result in their enhanced survival, better engraftment,
and improved reconstruction.
The nuclear factor E2-related factor 2 (Nrf2) is a tran-
scription factor critical for protection against electrophilic
and oxidative stresses (Surh et al. 2008; Zhu et al. 2006a).
When challenged by the stresses, Nrf2 induces transcription
of diverse antioxidants and detoxification enzymes that
eventually play an important role to ameliorate oxidative
stress-induced injuries in the cells (Jin et al. 2009; Element
2004; Levonen et al. 2007; Osburn et al. 2006).
In this study, we employed these properties of Nrf2 to
equip MSCs with this cytoprotective factor to withstand the
cytotoxic conditions.
In this regard, we transiently over-expressed the human
Nrf2 gene in MSCs using adenoviral expression system and
examined whether Nrf2 producing MSCs show improved
anti-oxidative and anti-apoptotic capabilities over unmodi-
fied MSCs in vitro. Application of Nrf2 transcription factor,
which itself induces several antioxidants, may be a better
approach than transferring the gene of individual antioxi-
dants. Our results can provide important clues to increase
the stability of MSCs for improving the efficacy of mesen-
chymal stem cell therapy.
Methods and materials
Isolation, cultivation, and identification of MSCs
Human bone marrow (BM) aspirate was obtained from
Hematopoietic Stem Cell Transplantation Facility of the
Shariati hospital under an institutional protocol and consent
procedure. MSCs were isolated from bone marrow of
healthy human volunteers and expanded according to Song
et al. (2005) based on their adherence to tissue culture
surfaces. Whole marrow cells were cultured at a density of
1×106 cells/cm2 in Dulbecco's modified Eagle's medium
containing 1 g glucose/L (DMEM-LG) (Gibco, USA),
10% fetal bovine serum (FBS; Invitrogen, USA), 100 U
penicillin/ml, and 100 mg streptomycin/ml (Sigma, USA).
Non-adherent cells were removed by changing the medium
after 72 h and every 4 days thereafter. Then the monolayer,
expected to be MSCs, was expanded by two passages. The
characteristics of MSCs were tested by immunophenotyping
and differentiation capacities. To confirm the identity of the
cultured MSCs, they were harvested, washed with PBS, and
labeled with the following fluorescin isothiocyanate (FITC)
or phycoerythrin (PE) (Becton-Dickinson) conjugated anti-
bodies: CD14, CD105, CD73, CD166, CD45, CD34, and
CD90. Mouse-IgG1-FITC and IgG1-PE were used as iso-
type controls. The labeled cells were assayed by flow
cytometry and analyzed with FloMax Software. MSCs were
also functionally characterized by in vitro differentiation
assays.
Adenovirus-mediated expression of Nrf2
Recombinant adenoviruses were produced using Gateway
pAd/CMV/V5-DEST vector and ViraPower Adenoviral
Expression System (Invitrogen), according to the manufac-
turer's instructions. The bone marrow-isolated MSCs were
used as a source of Nrf2 gene. The cells were cultured in
25 cm2 cell culture flasks and were grown in DMEM-LG
(Gibco, USA) supplemented with 10% fetal bovine serum
(FBS; Invitrogen, USA) 100 U penicillin/ml and 100 mg
streptomycin/ml (Sigma, USA)in a humidified atmosphere
of 5% CO2 and 95% air at 37°C. In order to induce expres-
sion of Nrf2, the MSCs were UV irradiated for 1 h, and then
subjected to RNA extraction by a commercial kit according
to the manufacturer's protocols (Invitrogen, Carlsbad, CA,
USA). Full-length cDNAs of Nrf2 were amplified through
RT-PCR using specific forward 5′-CACCATGGGAATG
GACTTGGAGCTGCC-3 ′and reverse 5 ′-CTAGTTT
TTCTTAACATCTGGCTTCTTAC-3′ primers. The ampli-
fied cDNA fragment was cloned into the pENTER/TEV/D-
TOPO vector using the pENTER Directional TOPO Clon-
ing kit (Invitrogen). The fidelity of Nrf2 coding sequence in
the pENTER/TEV/D-TOPO vector was confirmed by DNA
sequencing. Finally, the Nrf2 expression cassette was trans-
ferred from the pENTR gateway vector to the adenovirus
expression plasmid pAd/CMV/V5-DEST (Invitrogen Life
Technologies) through homologous recombination by using
LR clonase II.
To obtain virus particles, the pAd/CMV plasmids carry-
ing the desired gene were linearized by PacI restriction
endonuclease and mixed with Lipofectamine 2000 (Invitro-
gen) in Opti-MEMmedium (Invitrogen) and transfected into
sub-confluent 293A cells (a subclone of the 293 cell line).
Then, the 293A cells were cultured in DMEM-HG (Gibco,
USA) medium containing 10% fetal calf serum, and the
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medium was replaced every 2 days until 80% of the cells
detached from plates. The viral particles were harvested
with three cycles of freeze/thawing followed by centrifuga-
tion at 1,750×g for 15 min. To amplify viral titer, the cell
lysates were added to fresh 293A cells, and cultured for
several days until all cells were detached. After three con-
secutive amplification rounds, the collected adenovirus-
containing media were used as virus stock. The number of
viral particles (VP) was determined by end-point dilution
assay as described previously (Weng et al. 2009). Multiplic-
ity of infection was defined as the ratio of total number of
plaque-forming units to the total number of cells that were
infected. As a control, the pAd/CMV/V5-GW/lacZ vector
(Invitrogen) was digested with PacI and transfected into
293A cells to produce lacZ-bearing adenoviruses. Aliquots
of the adenovirus-containing medium were added to the
cells for subsequent analyses.
RT-PCR and Western blot analyses
RT-PCR was used for isolation of the Nrf2 cDNA and also to
evaluate the expression of Nrf2, SOD-1, SOD-2, and HO-1.
To assess the expression of Nrf2 by RT-PCR, total cell
RNA was extracted and used at concentration of 500 ng/μl
to construct cDNA using First Strand cDNA Synthesis
Superscript kit (Invitrogen) according to the manufacturer's
protocol. The sequence of primer pairs used for each reac-
tion are shown in Table 1. PCR condition included a primary
denaturation step of 5 min at 94°C, followed by 33 cycles of
30 s at 94°C, 30 s at appropriate annealing temperature, and
45 s at 72°C, and a final extension step of 5 min at 72°C.
Finally, 7 μl of each PCR product were analyzed by 2%
agarose gel electrophoresis. β-actin expression was also eval-
uated for normalization.
Western blot analysis was performed to detect the expres-
sion of Nrf2 protein. Total cell proteins were released using
Complete Lysis M reagent (Roche, Germany) according to
the manufacturer's instruction. Then, the samples were
boiled in loading buffer containing 4% sodium dodecyl
sulfate (SDS), 20% glycerol, and bromophenol blue for
5 min. Then, the proteins were resolved on 12% SDS-PAGE
and transblotted onto polyvinylidene fluoride (PVDF) mem-
brane (Roche, Germany) followed by blocking and overnight
incubation at 4°C with specific primary antibodies, i.e.,
β-actin (Sigma, USA) or polyclonal anti-Nrf2 antibodies
(Santa Cruz biotechnology, Santa Cruz, CA, USA). After-
wards, the membranes were washed with tris-buffered saline
(TBS) containing 0.1% Tween 20 and incubated with second-
ary HRP (horse raddish peroxidase) conjugated antibodies
(Sigma). Finally, the membranes were developed by DAB
solution (Sigma).
Differentiation studies
The basic differentiation potential of V-Nrf2-MSCs and
V-MSCs into three mesenchymal lineages of osteogenic,
adipogenic, and chondrogenic was evaluated. In this
regard, MSCs were expanded in Dulbecco's Modified
Eagle Medium containing 10% FBS and seeded into
StemPro® osteogenesis, adipogenesis, or chondrogenesis
differentiation media (Invitrogen) in 24-well tissue culture
plates according to the manufacturer's protocol. Cultures were
refed every 2 to 3 days. After 1–3 weeks, the cultures were
monitored for differentiation using lineage-specific biologic
stains. MSCs expanded in standard growth medium (DMEM+
10% FBS) was used as negative control.
For assessment of adipogenic differentiation, 8 days after
incubation of the MSCs under differentiating condition, they
were stained with HCS LipidTOX™ Green, washed with
Dulbecco's phosphate-buffered saline (DPBS) and visual-
ized under fluorescent microscope. For evaluation of chon-
drogenic differentiation, 15 days after incubation of the cells
under differentiating conditions, micromass pellet cultures
were stained with 1% Alcian Blue solution prepared in
0.1 N HCl. Then, the cells were washed with 0.1 N HCl
and visualized under light microscope. To assess osteogenic
differentiation, after 3 weeks of culturing under differentiat-
ing condition, the cells were stained with 2% Alizarin Red S
solution and visualized. The positive areas of staining were
(at least 50 areas that were obtained by three independent
experiments performed in triplicate) quantified using Image
J software (version 1.42, National Institutes of Health,
Bethesda, Maryland) as previously described (Kamiya et
al. 2006).
Measurement of SOD and HO-1 activities
The bilirubin concentration of the culture media was quan-
tified as reported by Tsai et al. (2006) and Turcanu et al.
(1998)) to determine HO activity. Briefly, porphyrins were
added to the cells and after incubation in dark, culture
supernatant was mixed with barium chloride (250 mg) and
benzene (750 μl) followed by vigorous vortexing leading to
Table 1 Sequences of the primers used in RT-PCR studies
Sequence Primer name No.
5′-AGGGCATCATCAATTTCGAGC-3′ Forward SOD1 1
5′-ACATTGCCCAAGTCTCCAAC-3′ Reverse SOD1 2
5′-GGAAGCCATCAAACGTGACT-3′ Forward SOD2 3
5′-CCTTGCAGTGGATCCTGATT-3′ Reverse SOD2 4
5′-CACCATGGAGCGTCCGCAACC
CGAC-3′
Forward HO-1 5
5′-TTGTTGCGCTCAATCTCCTCC
TCC-3′
Reverse HO-1 6
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formation of a relatively stable milky-white emulsion and
centrifuged at 13,000×g for 30 min. The upper benzene layer
containing bilirubin was collected, and the produced bilirubin
was quantified spectrophotometrically. The HO activity was
measured as picomoles of bilirubin formed per milligram of
cell protein. The SOD activity was determined by measuring
sample-mediated inhibition of xanthine oxidase-dependent
O2
− (superoxide radical) production using Superoxide
Dismutase Assay II kit as instructed by the manufacturer
(Calbiochem). Briefly, after harvesting 1×106 cells by scrap-
ing and centrifugation at 1,000×g for 10 min, they were
subjected to protein extraction by 1 mL of SOD lysis buffer
(20 mM HEPES, 1 mM ethylene glycol tetra acetic acid
(EGTA), 210 mM mannitol, 70 mM sucrose, and 0.1% (v/v)
Triton X-100; pH 7.2). Then, the lysate was centrifuged at
1,500×g and 4°C for 5 min. The supernatant was then added
to chromogenic tetrazolium salt (free radical detector), and
xanthine oxidase was supplemented as an enzymatic source of
O2
− (superoxide radical). Following 20 min of incubation at
room temperature, absorbance was read at 450 nm. One unit
of SOD is defined as the amount of enzyme needed to exhibit
50% dismutation of the superoxide radical.
Cell survival assay following in vitro treatment of MSCs
with different stresses
For oxidative stress experiments, 2×104 cells/well were
seeded in a 96-well plate and 12 h later, the cells were
exposed to 1–10 mM hydrogen peroxide (H2O2) (Sigma,
Dusseldorf, Germany) for various time lengths. For serum
deprivation (SD) stress, the MSCs were washed three times
with serum-free medium and maintained at this condition
for various time lengths. Hypoxia was achieved by placing
the cells in Galaxy 48 R Incubator (New Brunswick, Ger-
many). These cells were incubated at 37°C, in the presence
of 5% CO2 and 1% O2 in N2 (hypoxia) for different time
lengths. Each test was performed in triplicate and at appro-
priate time points, the cytotoxic effects of H2O2, hypoxia, or
serum deprivation were determined by trypan blue dye
exclusion and MTT assays. To perform MTT assay, 3-(4,5-
dimethlthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT, Sigma, Dusseldorf, Germany) was added to the cells
at 0.5 mg/ml final concentration and incubated at 37°C in a
5% CO2 atmosphere for 4 h. Finally, the reaction was
stopped by addition of 10% SDS and 0.01 M HCl. When
the insoluble crystals were dissolved completely, absor-
bance of the mixture was read at 570 nm.
Assessment of cell apoptosis by annexin-V/propidium
iodide staining and caspase 3 evaluation
Induction of apoptosis in V-Nrf2-MSCs by different stresses
was evaluated using Annexin-V-FLUOS staining kit (Roche
Diagnostics, Germany) according to the manufacturer's
instructions. In brief, approximately, 2×105 cells were har-
vested, washed twice with PBS, and resuspended in incuba-
tion buffer containing annexin-V-FITC and propidium
iodide. The mixture was incubated for 15 min at room
temperature and analyzed using a flow cytometer (Partec)
and FloMax software.
Caspase-3 activity was measured by a colorimetric
caspase-3 assay kit according to the manufacturer's protocol
(PharMingen, Germany). The cells were seeded in 24-well
plates at a density of 3×105 cells/well and incubated at 37°C
in a 5% CO2 atmosphere. Following treatment of the cells
with different stresses, they were washed with PBS, trypsi-
nized, and subjected to caspase-3 measurement according to
the manufacturer's protocol.
Statistical analysis
The statistical significance of the results was evaluated
using analysis of variance, ANOVA, and Student's t test.
In all tests, p<0.05 was considered significant.
Results
Characterization of MSCs
MSCs were isolated from BM cells by their adhesion to
tissue culture surfaces and consisted of a heterogeneous cell
population with a predominant spindle-shaped morphology
and were able to form fibroblast-like colonies. For further
evaluation of the human MSCs phenotype, cell-surface anti-
gens were analyzed by flow cytometry which confirmed
expression of characteristic markers for MSCs, i.e., CD166,
CD105, CD73, and CD90, while they were negative for
hematopoietic antigens like CD45, CD34, and CD14
(Hamedi-Asl et al. 2011) (Fig. 1).
Adenoviral-mediated gene delivery to MSCs
The MSCs were UV irradiated for 1 h to induce expression
of Nrf2. Amplification of Nrf2 cDNA is then performed
using specific primers and total cell RNA as template which
resulted in a single band of about 1,825 bp on agarose gel
electrophoresis (Fig. 2a). The PCR product is directionally
cloned into pENTR/D-TOPO which is a donor vector for
Gateway recombination cloning. PCR analysis of the
extracted recombinant plasmid confirmed the cloning of
the Nrf2 coding sequence into the pENTR/D-TOPO vector
(Fig. 2b). Then, the fidelity of the cloned sequence was
confirmed by sequencing (GenBank accession number
HM446346). Finally, the LR recombination reaction was
performed and proper recombination was confirmed by
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PCR analysis using gene specific primers for Nrf2 (data not
shown).
Transient expression of Nrf2 in MSCs using adenoviral
vector
Fourth passage of the MSCs was infected with appropriate
multiplicity of infection (MOI) of the recombinant adenovirus
vector harboring the Nrf2 (Ad-hNrf2) coding sequence or the
control viral vector (Ad-V). RT-PCR was used to compare
changes in the expression of Nrf2 at different time points (1, 2,
4, 6, 8, 10, 12, and 14 days post-infection). Initial expression
of Nrf2 was detected on day 2 and increased to the highest
expression level at day 6, then it decreased thereafter and no
expression was detected on day 14 (Fig. 3a). Accordingly, the
highest expression level of Nrf2 protein was also detected by
Western blotting at day 6 (Fig. 3b). Many attempts failed to
detect the expressed Nrf2 protein in other days by western blot
analysis using DAB staining method. These results indicated
the transient overexpression of Nrf2. Most of the transduced
MSCs continuously adhered to the tissue culture dishes, and
no distinct morphological changes were observed.
Nrf2 modified MSCs maintained their multi-differentiation
capacity
Osteogenic, adipogenic, and chonderogenic differentia-
tions are considered the functional standards for MSC
precursors. Therefore, to evaluate the possible effects of
Nrf2 expression on the differentiation capacity of the
Nrf2-MSCs, they were induced toward adipogenic,
chondrogenic, and osteogenic differentiation 5 days
post-infection.
After 7 days of induction toward the adipogenic lineage,
considerable morphological changes with lipid vacuole ac-
cumulation were observed (Fig. 4b). Following 21 days of
osteogenic differentiation, positive staining for Alizarin Red
S confirmed the ability of Nrf2-MSCs to differentiate into
osteocytes (Fig. 4c). After 15 days of chondrogenic induc-
tion, synthesis of proteoglycans by chondrocytes was
detected following Alcian blue staining (Fig. 4d). Positive
area analysis with Image J software used to obtain quanti-
tative results.
As shown in Fig. 4e, multilineage differentiation capa-
bility of Nrf2-MSCs was slightly decreased, but there was
Fig. 1 Flow cytometric analysis indicates thatMSCs are positive for the antigens CD166, CD105, CD90, andCD73 but negative for CD45,CD34, andCD14
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no significant difference compared to the control cells (Ad-
MSC). Taken together, these results indicated that the Nrf2-
MSCs retained their normal ability to differentiate into
adipogenic, chondrogenic, and osteogenic lineages.
Nrf2 induces SOD-1, SOD-2, and HO-1 in MSCs
Induction of antioxidants is one of the well-known
functions of Nrf2. Superoxide dismutases (SODs) and
heme oxygenase 1 (HO-1) are two important antioxi-
dants induced by Nrf2. Therefore, to determine whether
Nrf2 would also induce expression of these antioxidants in
MSCs, we evaluated the expression of SOD-1, SOD-2, and
HO-1 by RT-PCR in both Nrf2-MCSs and V-MSCs. As
shown in Fig. 5a, b, Nrf2 upregulates the expression of
SOD-1, SOD-2, and HO-1. The activity of SODs and HO-1
was also measured by commercially available kits. As shown
in Fig. 5c, Nrf2 also enhances the activity of SODs and HO-1.
These findings suggest that the cytoprotective effects of Nrf2
may be attributed to the induction of theses enzymes.
Nrf2 protects MSCs against H2O2, hypoxia, and serum
deprivation induced-toxicities
To determine whether Nrf2 can protect human bone
marrow-derived MSCs against the stresses which MSCs
will inevitably face, the Nrf2 expressing cells were
exposed to hydrogen peroxide, hypoxia, and serum dep-
rivation for different time lengths and then subjected to
cytotoxicity and proliferation assays. Exposure of the
cells to 1 mM hydrogen peroxide for 2 h did not
significantly change the viabilities of both Nrf2-MSCs
and V-MSCs. Nevertheless, hydrogen peroxide concen-
trations higher than 4 mM caused a severe decrease in
viabilities of both Nrf2-MSCs and V-MSCs (Fig. 6a).
However, following exposure of the cells to hydrogen
peroxide concentrations of 2–4 mM, the Nrf2-MSCs
were more resistant to cell death than the V-MSCs
confirming the cytoprotective effect of the Nrf2 over-
expression against hydrogen peroxide cytotoxicity (Fig. 6a).
Both Nrf2-MSCs and V-MSCs were also exposed to serum
Fig. 2 a Isolation of Nrf2 cDNA. Two different clones of the mesen-
chymal stem cells were UV irradiated for 1 h to induce the Nrf2 gene
expression. Then, total RNAwas extracted and cDNAwas synthesized
by RT-PCR. There was no difference between these two clones. Fol-
lowing exposure of the cells to UV irradiation, the induction of Nrf2
expression was detected (1 and 2). M 1,000 bp DNA marker (upper
image). Expression of beta-actin was used for normalization.M 100 bp
DNA marker (lower image). b Cloning of the Nrf2 cDNA into pENTR/
D-TOPO plasmid. The blunt-end PCR product was TOPO-cloned into
the pENTR TOPO/D vector and used to transform competent E. coli
cells. Positive clones were selected on LB-agar medium containing
appropriate antibiotic. The recombinant plasmids were extracted from
resistant colonies and analyzed by PCR using the Nrf2 specific pri-
mers. Two clones (1 and 3) were positive for Nrf2. M 1,000 bp DNA
marker
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deprivation or hypoxia conditions for different time lengths
followed by cell viability assay (Fig. 6b, c). The higher
number of surviving Nrf2-MSCs comparing to the num-
ber of viable V-MSCs indicated the protective effects of
Nrf2 on MSCs against hypoxia/serum deprivation in-
duced toxicities.
Nrf2 expression protects MSCs against apoptosis in vitro
To study the effect of Nrf2 on apoptosis, which is one of the
well-known causes of MSCs death, the Nrf2-MSCs and
V-MSCs were exposed to hypoxia, serum deprivation, or
hydrogen peroxide for various time lengths. Subsequently,
induction of apoptosis was analyzed by Anexin V staining
and caspase assay kit. Following treatment of MSCs with
400 μM hydrogen peroxide for 24 h, the number of apoptotic
Nrf2-MSCs was significantly lower than the V-MSCs
(Fig. 7a). In case of exposure of the cells to hypoxia and serum
deprivation conditions, the number of apoptotic Nrf2-MCSs
was again lower than the number of apoptotic V-MCSs
(Fig. 7a).
Induction of apoptosis following exposure to the oxida-
tive conditions was also evaluated by assessment of the
activated caspase 3. As Fig. 7b represents, higher levels of
the activated caspase 3 was detected in V-MSCs comparing
to the Nrf2-MCSs. Taken together, these findings indicated
that the cytosolic overexpression of the Nrf2 protein protects
MSCs against the H2O2, serum deprivation, and hypoxia-
induced apoptosis.
Discussion
Despite the prominent promise of MSCs in regenerative
medicine by repopulating the damaged tissues and restoring
their function (Zhu et al. 2006b), their poor survival follow-
ing tissue implantation limited their therapeutic efficacy (Li
et al. 2007). The exact cellular mechanisms resulting in loss
of the MSCs are unclear, and very little is known about the
procedures that may mediate this process (Zhu et al. 2006b).
On the other hand, bone marrow is a common target of
numerous toxic agents, cancer chemotherapeutic drugs, and
environmental chemicals. Increasing evidences indicate the
role of oxidative and electrophilic stresses in bone marrow
depression and toxicity under various pathophysiological
conditions. This makes it important to determine pathways
controlling detoxification of these reactive intermediates in
bone marrow cells including MSCs.
Because of continuous exposure of cells to damaging
oxidizing agents, the oxygen-dependent organisms have
developed a highly evolutionarily conserved mechanism
for preventing oxidative stresses with Nrf2 as a key protein
in the cellular stress response (Braun et al. 2002).
It is noteworthy that hypoxia, serum deprivation, and oxi-
dative stresses are the well-known causes of MSCs death (Zhu
et al. 2006b). Interestingly, the expression of Nrf2 is up-
regulated under these conditions. Nrf2 also controls bone mar-
row stromal cell susceptibility to oxidative and electrophilic
stresses (Kim et al. 2007b; Yu 2007; Umemura et al. 2008).
These observations led us to the hypothesis that if MSCs are
Fig. 3 Transient expression of Nrf2 by the MSCs infected with the
recombinant adenovirus. (a upper image) RT-PCR analysis of the Nrf2
expression levels up to 14 days after infection of the MSCs with the
recombinant adenoviruses showed the highest expression level on day
6. No detectable expression was observed 2 weeks after infection. M
100 bp DNA marker. (a lower image) Expression of beta-actin was
used for normalization.M 100 bp DNA marker. bWestern blot analysis
of Nrf2 expression on day 6. Control MSCs revealed no detectable
Nrf2 protein expression. Lower figure represents the assessment of
beta-actin expression as a control for both group
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equipped with this cytoprotective factor, they would withstand
the cytotoxic conditions.
In this study, we expressed Nrf2 by using an adenoviral
expression system. This system has several advantages such
as transient and high expression levels and the simplicity of
infection conditions (Conget and Minguell 2000).
It should be noted that Nrf2 is induced in response to oxida-
tive stresses in most cell types and rapidly returns to its basal
levels and its continuous expression could be harmful to cells
(Kim et al. 2007b; Padmanabhan et al. 2006; Singh et al. 2006;
Kim et al. 2007a; Itoh et al. 1997; Rushmore and Tony 2002;
Nguyen et al. 2004). Therefore, it would be reasonable to use the
adenoviral expression system to take advantage of transient
expression of Nrf2 in MSCs in order to prevent the majority
of MSCs of being died a few days after transplantations.
Here, we showed that the differentiation capability of the
MSCs is not affected by their transduction with the Nrf2
harboring adenoviral vector, which suggests the potential
application of Nrf2 engineered MSCs for further in vivo
studies. Furthermore, efficient gene delivery with adenoviral
vectors in addition to the use of gateway technology adds
Fig. 4 Differentiation capacity
of the Nrf2-MSCs. MSCs
infected with Ad-Nrf2 were
cultured in osteogenic,
adipogenic, and chondrogenic
differentiation media. The
Nrf2-MSCs maintained their
multi-differentiation capacity.
a Control MSCs cultivated in
normal medium (DMEM low
glucose), b adipogenic differ-
entiation, c osteogenic differen-
tiation, and d chondrogenic
differentiation. e Measurements
of percent of positive area
showed no significant
difference between Nrf2-MSCs
and Ad-MSCs differentiation
capacities
Fig. 5 a RT-PCR analysis of the SOD-1, SOD-2, and HO-1 expression
by the Nrf2-MSCs. Expression of these genes was up-regulated in two
Nrf2 overexpressing clones.M 100 bp DNA marker. b Quantification of
the bands was analyzed by UVIdocGel Documentation System (Avebury
House 36a Union Lane Cambridge CB4 1QB-uk). cTotal SOD andHO-1
activities were compared between test (V-Nrf2) and control (V) groups.
Results showed significant enhancement of activities of these proteins
following Nrf2 overexpression (mean±SD; ***p<0.001; three indepen-
dent experiments were carried out)
b
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to the advantages of our study. In order to test the survival
rate of the MSCs, they were exposed to H2O2, serum depri-
vation, and hypoxia conditions. The results revealed that
overexpression of Nrf2 in the MSCs enhance their survival
and resistance to oxidative stresses. Several studies have dem-
onstrated that Nrf2 is up-regulated by hydrogen peroxide,
hypoxia, and serum deprivation stresses, and this is in favor
of the cell viability (Kim et al. 2007b; Yu 2007; Umemura et
al. 2008).
Supporting our study, in an in vivo study, Abdel-Mageed
et al. (2009) showed that intravenous administration of
MSCs following their genetic modification with extracellu-
lar superoxide dismutase improves survival in irradiated
mice. Additionally, Tang et al. (2005) demonstrated that
modification of MSCs by a hypoxia-regulatable HO-1
expressing vector increases the tolerance of engrafted MSCs
to hypoxia-re-oxygen injury in vitro and improves their
viability in ischemic hearts. More recently, in an in vitro
study, we showed that adenovirus-mediated expression of
the HO-1 protein within MSCs decreased cytotoxicity of
oxidative stresses and inhibited the apoptosis induced by
them (Hamedi-Asl et al. 2011). Wang et al. (2009) also
expressed HSP20 in MSCs using adenoviral expression
Fig. 6 a Cytotoxic effects of different H2O2 concentrations on theMSCs
infected with the recombinant construct or empty vector were determined
by MTT assay after 2 h of exposure. The viability of the MSCs infected
with the Ad-Nrf2 was higher than the cells infected with empty virus
(Ad-) at hydrogen peroxide concentrations of 2, 3, and 4 mM, indicating
that Nrf2 protects the cells against hydrogen peroxide toxicity. b Cyto-
toxic effects of serum deprivation (SD) on MSCs infected with the
recombinant construct or empty vector at different time points determined
by MTT assay. Twenty-four and 48 h following incubation of the cells
under SD, the number of viable cells in Nrf2-MSCswas higher than those
of MSCs infected with empty virus. This showed that Nrf2-MSCs
approximately expanded independent of serum. c The effect of incubation
under hypoxia condition on MSCs infected with the recombinant
construct or empty vector was determined by MTTassay at different time
points. Following 6 and 24 h of incubation of the cells under hypoxia
condition, Nrf2 protected theMSCs (mean±SD; **p<0.01 and ***p<0.001;
three independent experiments were carried out)
Fig. 7 Apoptotic effects of the H2O2, serum deprivation (SD), and
hypoxia treatment on the MSCs. a Evaluation of apoptosis using
annexin-V kit. After treatment of the cells with 400 μM H2O2, 24 h
of hypoxia or 3 days of serum deprivation, the number of apoptotic
cells was higher in cells transfected with the empty virus (V) compar-
ing to those infected with the Ad-Nrf2 virus. b Evaluation of apoptosis
by assessment of the activated caspase-3. Under the conditions de-
scribed above, the lower level of the activated caspase 3 was observed
in Nrf2-MSCs comparing to the control cells (mean±SD of three
independent experiments; ***p<0.001)
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system, and an improved heart function was observed in an
in vivo study. Our present study also further supports the
previous findings of Li et al. (2007) that showed inhibition
of apoptosis in bcl-2 engineered MSCs and improvement of
heart function.
Apoptosis is a well-known mechanism of cell death
affecting the viability of MSCs. On the other hand, one of
the well-known functions of Nrf2 is its anti-apoptotic effect.
Taking this into consideration, we proposed that the expres-
sion of Nrf2 by the MSCs might inhibit the activation of
programmed cell death within the sensitized cells. In sup-
port of this hypothesis, our results revealed lower numbers
of apoptotic Nrf2-MSCs comparing to the control cells. There
are two probable mechanisms for resistance of Nrf2-MSCs to
different stresses. First, Nrf2 signalingmay up-regulate certain
anti-apoptotic genes (Levonen et al. 2007; Ho et al. 2005;
Calkins et al. 2009; Nakaso et al. 2003). Another cytoprotec-
tive mechanism of Nrf2 may involve the paracrine effects by
secretion of growth factors (Imberti et al. 2007; Morigi et al.
2008). In the present study, upregulation of SOD-1, SOD-2,
and HO-1 expression were observed in Nrf2-MSCs compar-
ing to the control V-MCS.
Various studies have shown that Nrf2 induces antioxi-
dants with the two important examples of superoxide dis-
mutases (SODs) and heme oxygenases-1 (HO-1). Zhu et al.
(2006a) demonstrated a significant reduction in the consti-
tutive expression of antioxidants and phase 2 enzymes,
including SOD, in Nrf2−/− stromal cells as compared to
wild-type cells. Using oligonucleotide microarray analysis,
Lee et al. (2003) showed that SODs, HO-1, and many other
antioxidant genes are induced by Nrf2 transcription factor
(Zhu et al. 2006a; Surh et al. 2008; de Vries et al. 2008;
Copple et al. 2008; Lee et al. 2003).
Another study has shown that adenoviral-mediated Nrf2
overexpression or Nrf2-inducing drugs may have therapeutic
applications in vascular diseases in which inflammation and
oxidative stress play an important role. Also, it has been stated
that Nrf2 exert its beneficial effects via secretion of growth
factors and cytokines such as HO-1(Levonen et al. 2007).
In conclusion, the observed improvement in the resis-
tance of the MSCs to the oxidative and apoptotic stimuli
following transient overexpression of Nrf2 by adenoviral
vectors could be used as a graft cell death prevention strategy
in transplantation and may emerge as an alternative plan for
stem cell therapy. Equipping the MSCs with the Nrf2 tran-
scription factor which in turn induces several antioxidants
may be a more effective strategy than transferring individual
antioxidant gene.
However, a possible disadvantage of Nrf2 overexpres-
sion is the risk of tumor progression (Kim et al. 2007b;
Padmanabhan et al. 2006; Singh et al. 2006; Kim et al.
2007a; Itoh et al. 1997; Rushmore and Tony 2002; Nguyen
et al. 2004). It has been demonstrated that a hypoxic tumor
microenvironment increases transactivation of Nrf2 (Kim et
al. 2007a). Considering the function of Nrf2 in regulating a
battery of genes that act to detoxify cancer drugs and/or
attenuate drug-induced oxidative stress, the Nrf2 overex-
pression may play a role in increasing the resistance to
treatment (Kim et al. 2007b; Itoh et al. 1997; Rushmore
and Tony 2002; Nguyen et al. 2004).
Nevertheless, in case of short-term therapeutic or diag-
nostic gene therapies, the transient adenovirus-mediated
expression of the Nrf2 gene would be advantageous. Thus,
the adenoviral-mediated overexpression of the Nrf2 protein
within the MSCs is proposed for further studies to evaluate
the safety and efficacy of the Nrf2-MSCs in vivo.
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